CEO Brian Wong was paid $6,979,539 in fiscal year 2024, ↑ up 5.9% from fiscal year 2023 (SEC filing 0000950170-25-053517 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$6,979,539 ↑ Brian Wong total, FY2024 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | 76.48% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Brian Wong | $630,000 | $0 | $0 | $5,927,297 | $416,000 | $0 | $6,242 | $6,979,539 |
| President and Chief Executive Officer | ||||||||
| Rodney Young | 478,000 | 0 | 0 | 1,975,492 | 229,440 | 0 | 8,564 | 2,691,496 |
| Chief Financial Officer | ||||||||
| William Ho | 481,000 | 0 | 0 | 1,603,438 | 221,260 | 0 | 7,322 | 2,313,020 |
| Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Brian Wong | $6,979,539 | $6,591,617 | — | ↑ +387,922 |
| Rodney Young | 2,691,496 | 2,175,226 | — | ↑ +516,270 |
| William Ho | 2,313,020 | 1,903,926 | — | ↑ +409,094 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read RAPT Therapeutics's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper RAPT reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses RAPT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named RAPT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2024 total |
|---|---|---|
| Linda Kozick | Independent Director | $191,919 |
| Lori Lyons-Williams | Chair of the Board | $194,294 |
| Mary Ann Gray | Independent Director | $207,419 |
| Michael Giordano | Independent Director | $201,419 |
| Wendye Robbins | Independent Director | $194,919 |
| William Rieflin | Former director (through FY2024) | $232,419 |
Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Linda Kozick | Director | 2025-05-29 | A | 257,832 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2025-05-29 | A | 257,832 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2025-05-29 | A | 257,832 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2025-05-29 | A | 257,832 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2025-06-20 | A | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2025-06-20 | A | 118,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2025-06-20 | A | 637,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| William Ho | CHIEF MEDICAL OFFICER | 2025-06-20 | A | 75,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Braunstein | Director | 2025-06-21 | A | 25,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ashley L. Dombkowski | Director | 2025-06-21 | A | 25,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ashley L. Dombkowski | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Scott Braunstein | Director | 2026-01-30 | A | 4,956 | 0 | 0 | Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 402 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 498 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 2,813 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 64,102 | — | — | Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 2,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 80,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Braunstein | Director | 2026-03-03 | D | 25,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 417 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 521 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 31,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 4,648 | — | — | Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 69,271 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 478 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 32,229 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 1,063 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 2,813 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 1,618 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lori Lyons-Williams | Director | 2026-03-03 | D | 4,561 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 32,229 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 1,618 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 1,063 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 1,917 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 32,229 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 4,561 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 1,618 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 521 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 2,083 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 560 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 32,229 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 7,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 4,561 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 1,072 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 1,618 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 1,063 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Mary Ann Gray | Director | 2026-03-03 | D | 484 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Braunstein | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Linda Kozick | Director | 2026-03-03 | D | 1,063 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 371,875 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 218,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 34,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 18,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 7,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 10,417 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 8,334 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Brian Wong | Director | 2026-03-03 | D | 25,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 58,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 64,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 9,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 7,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 6,876 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 6,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 3,125 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 1,035 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | D | 1,225 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 11,251 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 8,501 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 8,125 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 7,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 17,501 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rodney Young | CHIEF FINANCIAL OFFICER | 2026-03-03 | D | 3,304 | — | — | Common | Form 4 ↗ |
| Ashley L. Dombkowski | Director | 2026-03-03 | D | 25,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Ashley L. Dombkowski | Director | 2026-03-03 | D | 4,956 | — | — | Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 4,561 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 938 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 799 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Giordano | Director | 2026-03-03 | D | 824 | — | — | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Rodney Young | RSU | 47,395 | — | $17,605 |
| Brian Wong | RSU | 119,791 | — | 44,494 |
| William Ho | RSU | 40,104 | — | 14,896 |
| Brian Wong | RSU | 146,875 | — | 54,554 |
| Brian Wong | RSU | 218,750 | — | 81,250 |
| Rodney Young | RSU | 140,000 | — | 52,003 |
| Brian Wong | RSU | 83,333 | — | 30,952 |
| Brian Wong | RSU | 63,020 | — | 23,407 |
| Rodney Young | RSU | 58,750 | — | 21,823 |
| Rodney Young | RSU | 32,583 | — | 12,103 |
| Brian Wong | RSU | 60,000 | — | 22,286 |
| William Ho | RSU | 53,854 | — | 20,003 |
| William Ho | RSU | 26,833 | — | 9,967 |
| Rodney Young | RSU | 20,635 | — | 7,665 |
| William Ho | RSU | 20,000 | — | 7,429 |
| William Ho | RSU | 17,187 | — | 6,384 |
| William Ho | RSU | 7,807 | — | 2,900 |
We have a pay-for-performance focused executive compensation philosophy designed to drive company performance aimed at increasing stockholder value. We seek to achieve this by using a market-based approach to attract, retain, and motivate a high-performing team of executive officers and by aligning most of the compensation of each of our executives with the Company’s short- and long-term performance, as well as each such executive’s individual contributions.
| CEO STI target (% of salary) | 55% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon plc/Radford |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-05-29 | 76,867,722 | 23,639,125 | 55,527 | 76.48% | Passed |
| 2024 | 2024-05-22 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-05-29 | 76.48%a |
| 2024 | 2024-05-22 | —b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| William RieflinIndependent | $90,000 | $0 | $142,419 | — | $0 | $232,419 |
| Mary Ann GrayIndependent · Audit (Chair) | 65,000 | 0 | 142,419 | — | 0 | 207,419 |
| Michael GiordanoIndependent · Compensation (Chair) · Nominating and Corporate Governance | 59,000 | 0 | 142,419 | — | 0 | 201,419 |
| Wendye RobbinsIndependent · Audit · Not standing for re-election | 52,500 | 0 | 142,419 | — | 0 | 194,919 |
| Lori Lyons-WilliamsIndependent · Board Chair · Compensation · Nominating and Corporate Governance | 51,875 | 0 | 142,419 | — | 0 | 194,294 |
| Linda KozickIndependent · Audit · Nominating and Corporate Governance (Chair) | 49,500 | 0 | 142,419 | — | 0 | 191,919 |
| Brian WongEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $367,875 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $367,875 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | RAPT Therapeutics | 2024 | Brian Wong | $630,000 | $0 | $5,927,297 | $416,000 | $6,979,539 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Brian Wong | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Executive Compensation”. As printed: 6,979,539. Filing ↗machine: r2 · c23 · span 816852–816861 |
| 2 | Section 01, Rodney Young | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Executive Compensation”. As printed: 2,691,496. Filing ↗machine: r6 · c23 · span 849443–849452 |
| 3 | Section 01, William Ho | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Executive Compensation”. As printed: 2,313,020. Filing ↗machine: r4 · c23 · span 833172–833181 |
| 4 | Section 08, William Rieflin | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 232,419. Filing ↗machine: span 1108600–1108809 |
| 5 | Section 08, Mary Ann Gray | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 207,419. Filing ↗machine: span 1118925–1119134 |
| 6 | Section 08, Michael Giordano | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 201,419. Filing ↗machine: span 1113762–1113971 |
| 7 | Section 08, Wendye Robbins | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 194,919. Filing ↗machine: span 1129240–1129449 |
| 8 | Section 08, Lori Lyons-Williams | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 194,294. Filing ↗machine: span 1134399–1134608 |
| 9 | Section 08, Linda Kozick | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 191,919. Filing ↗machine: span 1124077–1124286 |
| 10 | Section 08, Brian Wong | DEF 14A | 2025-04-14 | 0000950170-25-053517 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 11 | Section 02, Linda Kozick 2025-05-29 | Form 4 | 2025-06-02 | 0001415889-25-015196 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 12 | Section 02, Lori Lyons-Williams 2025-05-29 | Form 4 | 2025-06-02 | 0001415889-25-015216 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 13 | Section 02, Michael Giordano 2025-05-29 | Form 4 | 2025-06-02 | 0001415889-25-015230 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 14 | Section 02, Mary Ann Gray 2025-05-29 | Form 4 | 2025-06-02 | 0001415889-25-015224 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 15 | Section 02, Dirk G. Brockstedt 2025-06-20 | Form 4 | 2025-06-24 | 0001415889-25-018062 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 16 | Section 02, Rodney Young 2025-06-20 | Form 4 | 2025-06-24 | 0001415889-25-018063 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Brian Wong 2025-06-20 | Form 4 | 2025-06-24 | 0001415889-25-018067 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, William Ho 2025-06-20 | Form 4 | 2025-06-24 | 0001415889-25-018072 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Scott Braunstein 2025-06-21 | Form 4 | 2025-06-24 | 0001415889-25-018080 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Ashley L. Dombkowski 2025-06-21 | Form 4 | 2025-06-30 | 0001415889-25-018579 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Ashley L. Dombkowski 2026-01-30 | Form 4 | 2026-02-02 | 0001270774-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Linda Kozick 2026-01-30 | Form 4 | 2026-02-02 | 0001782274-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Mary Ann Gray 2026-01-30 | Form 4 | 2026-02-02 | 0001261974-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Lori Lyons-Williams 2026-01-30 | Form 4 | 2026-02-02 | 0001693564-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Michael Giordano 2026-01-30 | Form 4 | 2026-02-02 | 0001733915-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Scott Braunstein 2026-01-30 | Form 4 | 2026-02-02 | 0001643875-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Scott Braunstein 2026-03-03 | Form 4 | 2026-03-05 | 0001643875-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Lori Lyons-Williams 2026-03-03 | Form 4 | 2026-03-05 | 0001693564-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Mary Ann Gray 2026-03-03 | Form 4 | 2026-03-05 | 0001261974-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Scott Braunstein 2026-03-03 | Form 4 | 2026-03-05 | 0001643875-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Linda Kozick 2026-03-03 | Form 4 | 2026-03-05 | 0001782274-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Brian Wong 2026-03-03 | Form 4 | 2026-03-05 | 0001646110-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Dirk G. Brockstedt 2026-03-03 | Form 4 | 2026-03-05 | 0001635616-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Rodney Young 2026-03-03 | Form 4 | 2026-03-05 | 0001337831-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Ashley L. Dombkowski 2026-03-03 | Form 4 | 2026-03-05 | 0001270774-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Ashley L. Dombkowski 2026-03-03 | Form 4 | 2026-03-05 | 0001270774-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Michael Giordano 2026-03-03 | Form 4 | 2026-03-05 | 0001733915-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 06, 2025 vote | Form 8-K | 2025-05-29 | 0000950170-25-079023 | Item 5.07 · say-on-pay result. As reported: 76.48% (votes for as printed: 76,867,722). Filing ↗ |
| 104 | Section 06, 2024 vote | Form 8-K | 2024-05-23 | 0000950170-24-064001 | Item 5.07 · say-on-pay result. As reported: —. Filing ↗ |
| 105 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 106 | Section 09b board cost (computed) | Computed | — | — | Cash 367,875 + equity 0 + all other 0 = 367,875, summed across the director compensation table rows.machine: formula: Σ = 367,875 |
| 107 | RAPT Therapeutics (subject), Section 10b CEO total | DEF 14A | 2025-04-14 | 0000950170-25-053517 | CEO total compensation as printed in RAPT Therapeutics's own proxy. As printed: 6,979,539. Filing ↗machine: r2 · c23 · span 816852–816861 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.